Unternehmen in STUTTGART

BIOREGIO STERN MANAGEMENT GMBH

BeobachtenFeed abonnierenFörderungen als CSV

In 0 Bekanntmachungen genannt, seit 1. Januar 2018, aber in keiner als Auftragnehmer eines Zuschlags.

Fördermittel

Kohesio und Finanztransparenzsystem der EU, so gezählt.

11 Förderungen, zusammen 13,3 Mio. €.

QuelleBetragFörderungen
EU-Haushalt (Finanztransparenzsystem)1,4 Mio. €88
EU-Strukturfonds 2021 bis 2027 (Kohesio)12,0 Mio. €33
JahrProgrammProjektBetrag und Beleg
20262021TC16RFTN005EU-Strukturfonds 2021 bis 2027 (Kohesio)MedTech Circular Solutions for a Resource-Efficient and Sustainable Future in NWEMedTech Circular Solutions for a Resource-Efficient and Sustainable Future in NWE4.050.425 €Projektkosten gesamt
20252021TC16RFTN005EU-Strukturfonds 2021 bis 2027 (Kohesio)Step up the use for new approach methodologies to replace animal testingStep up the use for new approach methodologies to replace animal testing6.332.365 €Projektkosten gesamt
2024EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU83.625 €Mittelbindung
2024EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU33.463 €Mittelbindung
2024EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101191595 - NAMWISE - NAMS WITHIN INTEGRATED SAFETY & EFFICACY EVALUATION OF CHEMICALS AND PHARMACEUTICALS101191595 - NAMWISE - NAMS WITHIN INTEGRATED SAFETY & EFFICACY EVALUATION OF CHEMICALS AND PHARMACEUTICALS4.900 €Mittelbindung
2024EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101191595 - NAMWISE - NAMS WITHIN INTEGRATED SAFETY & EFFICACY EVALUATION OF CHEMICALS AND PHARMACEUTICALS101191595 - NAMWISE - NAMS WITHIN INTEGRATED SAFETY & EFFICACY EVALUATION OF CHEMICALS AND PHARMACEUTICALS65.103 €Mittelbindung
20242021TC16RFTN003EU-Strukturfonds 2021 bis 2027 (Kohesio)Optimizing usage of new technologies in rehabilitation to improve life quality of Central Europe inhabitantsOptimizing usage of new technologies in rehabilitation to improve life quality of Central Europe inhabitants1.578.033 €Projektkosten gesamt
2023EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU468.344 €Mittelbindung
2023EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101134833 - EHAB - EUROPEAN HUB FOR ADVANCED THERAPIES & BIOMATERIALS101134833 - EHAB - EUROPEAN HUB FOR ADVANCED THERAPIES & BIOMATERIALS59.824 €Mittelbindung
2022EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU101074495 - BIOMAN4R2 - BIOMANUFATURING EUROCLUSTER FOR RECOVERY AND RESILIENCE IN EU585.449 €Mittelbindung
2018EU Budget - European CommissionX - EACI - Executive Agency for Competitiveness and Innovation822057 - S3MARTMED - THE EUROPEAN STRATEGIC CLUSTER PARTNERSHIP FOR SMART SPECIALISATION INVESTMENTS IN MEDICAL TECHNOLOGIES822057 - S3MARTMED - THE EUROPEAN STRATEGIC CLUSTER PARTNERSHIP FOR SMART SPECIALISATION INVESTMENTS IN MEDICAL TECHNOLOGIES69.813 €Mittelbindung

Angaben aus den Bekanntmachungen

0 Nennungen seit 1. Januar 2018, zuletzt am 1. Januar 2018, dieser Organisation zugeordnet. Wie wir zuordnen

Anschrift
FRIEDRICHTSTR. 10, 70174 STUTTGART
USt-IdNr.
DE218941367
Schreibweisen
  • BIOREGIO STERN MANAGEMENT GMBH
  • BioRegio STERN Management GmbH